1996 to 2000 Bankruptcy Assistant/Assistant System Manager/ChapterCatholic Charities Elderly Services
1995 to 1995 SecretaryChinese Language School
1990 to 1995 TeacherUniversity of Guangzhou Guangzhou, CN 1988 to 1990 Lecturer of ChemistryInsturctor of Chemistry/College of Education, China
1982 to 1988
Education:
University of Hawaii Community Colleges 2000 Analysis/DesignThe Board of Education 1994 to 1995 Certificate of Data in MajoringNan Normal University 1988 Certificate of Lecturer in ChemistryShan University 1986 to 1987 Master's in MajoringNan Normal University 1984 Physical ChemistryThe South China Institute of Technology 1978 to 1982 Bachelor's in Physical Chemistry
Feb 2011 to 2000 Commodities Risk AnalystFidelity Investments, Asset Allocation Division Boston, MA Jan 2010 to Feb 2011 Quantitative AnalystIndustrial and Commercial Bank of China
Jul 2006 to Jun 2007 FX Sales and Trading Analyst
Education:
Columbia University, Graduate School of Arts and Sciences New York, NY Sep 2007 to Feb 2009 MA in StatisticsEast China University of Science and Technology New York, NY Sep 2002 to Jul 2006 BS in Mathematics and Applied Mathematics
The present application describes novel spiro-cyclic -amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF- converting enzyme (TACE), and/or aggrecanase inhibitors.
Spiro-Cyclic Β-Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-Α Converting Enzyme (Tace)
The present application describes novel spiro-cyclic β-amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF-α converting enzyme (TACE), and/or aggrecanase inhibitors.
Substituted 2-Quinolyl-Oxazoles Useful As Pde4 Inhibitors
Rongze Kuang - Green Brook NJ, US David Blythin - North Caldwell NJ, US Neng-Yang Shih - Warren NJ, US Xiao Chen - Edison NJ, US Jianhua Cao - Edison NJ, US Danlin Gu - Kirkland WA, US Ying Huang - Berkeley Heights NJ, US John H. Schwerdt - Lake Hiawatha NJ, US Pauline C. Ting - New Providence NJ, US Li Xiao - Cranbury NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 215/38 A61K 31/44
US Classification:
514312, 514314, 546153, 546159
Abstract:
The invention claims compounds of the formula.
Maleate, Tosylate, Fumarate And Oxalate Salts Of 5-(1-(S)-Amino-2-Hydroxyethyl)-N-[(2,4-Difluorophenyl)-Methy]-2-[8-Methoxy-2-(Triflouromethy)-5-Quinoline]-4-Oxazolecarboxamide And Preparation Process Therefore
Xiaoming Chen - Westfield NJ, US Xiao Chen - Edison NJ, US Jianguo Yin - Plainsboro NJ, US Xiaoyong Fu - Edison NJ, US David J. Blythin - North Caldwell NJ, US Rongze Kuang - Green Brook NJ, US Scott Trzaska - Raritan NJ, US Chee-Wah Tang - Singapore, SG Vincenzo Liotta - Glen Ridge NJ, US Zaher Shabani - Budd Lake NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 215/38
US Classification:
546167
Abstract:
Disclosed are maleate, tosylate, fumarate, and oxalate salts of the compound 5-(1(S)-Amino-2-Hydroxyethyl)-N-[(2,4-Difluorophenyl)-Methyl]-2-[8-Methoxy-2-(Trifluoromethyl)-5-Quinoline]-4-Oxazolecarboxamide, represented by Formula I, and methods of preparing the same.
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
Dennis Yamashita - Wayne PA, US Xiao Tao Chen - Furlong PA, US
Assignee:
Trevena, Inc. - King of Prussia PA
International Classification:
C07K 7/06
US Classification:
514 37, 530328, 514 217, 514 164
Abstract:
This application describes compounds acting as, for example, β-arrestin effectors and uses thereof, in, for example, the treatment of chronic and acute cardiovascular diseases.
- New Brunswick NJ, US Ajit Parhi - New Brunswick NJ, US Gifty A. Blankson - New Brunswick NJ, US Liping Wang - Monmouth Junction NJ, US Xiao Chen - Monmouth Junction NJ, US Yongzheng Zhang - Monmouth Junction NJ, US Malvika Kaul - New Brunswick NJ, US Daniel S. Pilch - New Brunswick NJ, US
Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I.
Hong Kong people should have a world view, and not only focus on one citys arguments. Its not easy for the U.S. to create a disturbance in China, but its super easy to rock the boat through Hong Kong, Xiao Chen wrote.